Quick Dispatch:
Your semaglutide on shortage list Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your semaglutide on shortage list Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s ships.
Need Help?
Questions about semaglutide on shortage list Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for semaglutide on shortage list Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s in your area.
GLP-1 Drugs: FDA Removes Semaglutide from the Drug Shortage List
20.80
FDA Declares Shortage of Novo Nordisk's Wegovy, Ozempic Over
20.75
An Ongoing Crisis: Semaglutide Shortage Raises Dual Concerns for Obesity and Diabetes Treatment
21.75
As of February 21, 2025, the FDA updated its drug shortage list, marking the semaglutide injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A
29.58
The Risks of Compounded Semaglutide Products
29.84
New study suggest weight loss drugs may help lower risk of certain cancers
20.47
FDA says that the GLP-1 shortage is over
23.15
